Due to the prominent role of glutamate in neurologic diseases (Gu et al., 2014), therapies that inhibit glutamate-induced cell necrosis by Pin1-CAST/calpain2 pathway could be a novel therapeutic targets for the prevention of glutamate excitotoxicity. Here, CAST is linked to nervous system disorder.